Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

NCT02600507 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

529

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: Lumateperone (ITI-007)
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.